Information Library

Results for: Capital - Market Access

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • UK Market Access Insight Brief

    White Paper — May 30, 2012
    Insight Briefing series on Market Access in key European countries

  • Bridging Cultures

    Case Study — May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • Emerging Biopharma Service Fact Sheet

    Brochure — May 4, 2010
    Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies.

  • PharmAsia News Article Reprint

    Media Coverage — March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE

    Press Release — January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.

  • Poised for success

    Presentation — June 16, 2009
    Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility

Page 1 of 1 (6 results)

Subscribe to Email Based on Your Interests

Set preferences